Abstract:Metformin (Met) can improve atherosclerosis (As). Abnormal endothelin receptors [including endothelin type A (ETA) or type B (ETB) receptor] in vascular smooth muscle cells (VSMCs) are involved in As. Hyperhomocysteinemia (HHcy) is an independent risk factor for As. The present study was designed to test our hypothesis that Met inhibits the upregulation of endothelin receptors induced by homocysteine (Hcy) in VSMCs. Rat superior mesenteric artery (SMA) without endothelium, as an in vitro model, was cultured in serum-free medium for 24 h in the presence of Hcy with or without Met or nicotinamide (Nic). In vivo, rats received subcutaneous injections of Hcy in the presence or absence of Met or Nic for 3 weeks. Levels of protein expression were determined by Western blotting. The contractile responses to sarafotoxin 6c (an ETB receptor agonist) or ET-1 (an ETA/ ETB receptor agonist) were studied using a sensitive myograph. The blood pressure of rats was measured using a noninvasive tail-cuff plethysmography method. The results showed that Met could significantly inhibit the Hcy-induced upregulation of endothelin receptors (including ETA and ETB receptor) protein expression and endothelin receptor-mediated vasoconstriction, and it recovered the Hcy-induced decrease in silent information regulator 1 (Sirt1) in a dosage-dependent manner in SMA. However, Nic (a Sirt1 inhibitor) recovered the levels of Met-inhibited endothelin receptors and acetylated p65. Furthermore, the in vivo results showed that Met not only significantly the inhibited HHcy-induced upregulation of endothelin receptors and acetylated p65 but also recovered the HHcy-induced decrease in Sirt1 in a dosage-dependent manner in SMA. In addition, Met significantly inhibited the HHcy-induced blood pressure elevation. However, these effects were reverted by Nic. In conclusion, these data demonstrated that Met inhibited the Hcy-induced increase in endothelin receptor expression by activating Sirt1 and then inhibiting NF-κB in VSMCs. These findings may provide insights into the mechanism underlying of Met-treated cardiovascular diseases induced by Hcy.

Homocysteine Up-Regulates Endothelin Type A Receptor in Vascular Smooth Muscle Cells Through Sirt1/ERK1/2 Signaling Pathway.

The Sirt1/nf-Kb Signaling Pathway is Involved in Regulation of Endothelin Type B Receptors Mediated by Homocysteine in Vascular Smooth Muscle Cells.

Homocysteine Regulates Endothelin Type B Receptors in Vascular Smooth Muscle Cells.

Homocysteine Up-Regulates ETB Receptors Via Suppression of Autophagy in Vascular Smooth Muscle Cells

Homocysteine Stimulates Nuclear Factor Κb Activity and Interleukin-6 Expression in Rat Vascular Smooth Muscle Cells

Effects of Homocysteine on the Expression of Matrix Metalloproteinase-2 in Rat Vascular Smooth Muscle Cells

Homocysteine Upregulates Soluble Epoxide Hydrolase in Vascular Endothelium in Vitro and in Vivo

Interference in mevalonate pathway ameliorates homocysteine-induced endothelium-dysfunction.

Metformin Inhibited Homocysteine-Induced Upregulation of Endothelin Receptors Through the Sirt1/NF-κB Signaling Pathway in Vascular Smooth Muscle Cells.

Effect of homocysteine on expression of interleukin-6 and NF-kappa B activity in cultured rat vascular smooth muscle cells

High Glucose Upregulates Endothelin Type B Receptors in Vascular Smooth Muscle Cells Via the Downregulation of Sirt1.

Resveratrol Down-Regulates Endothelin Type B Receptors in Vascular Smooth Muscle Cells Via Sirt1/ERK1/2/NF-кB Signaling Pathways

Homocysteine Causes Endothelial Dysfunction via Inflammatory Factor-Mediated Activation of Epithelial Sodium Channel (ENaC)

Homocysteine activates vascular smooth muscle cells by DNA demethylation of platelet-derived growth factor in endothelial cells

Endogenous Hydrogen Sulfide and ERK1/2-STAT3 Signaling Pathway May Participate in the Association Between Homocysteine and Hypertension.

Homocysteine Causes Vascular Endothelial Dysfunction by Disrupting Endoplasmic Reticulum Redox Homeostasis.

Homocysteine Reduces Protein S-Nitrosylation in Endothelium

Valsartan Attenuated Homocysteine-Induced Impaired Autophagy and ER Stress in Human Umbilical Vein Endothelial Cells

Homocysteine Induces Apoptosis of Human Umbilical Vein Endothelial Cells via Mitochondrial Dysfunction and Endoplasmic Reticulum Stress

Endoplasmic reticulum stress mediates homocysteine-induced hypertrophy of cardiac cells through activation of cyclic nucleotide phosphodiesterase 1C

Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation